We are live on ! Find out more
LFVN icon

LifeVantage

86 hedge funds and large institutions have $106M invested in LifeVantage in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

52% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 23

22% more capital invested

Capital invested by funds: $86.4M → $106M (+$19.4M)

8% more funds holding

Funds holding: 8086 (+6)

3.83% more ownership

Funds ownership: 44.68%48.51% (+3.8%)

Holders
86
Holders Change
+6
Holders Change %
+7.5%
% of All Funds
1.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
35
Reduced
23
Closed
5
Calls
$777K
Puts
Net Calls
+$777K
Net Calls Change
-$59K

LFVN Hedge Fund Activity: Q4 2019 in Review

86 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in LifeVantage (LFVN) for Q4 2019, worth a combined $106M — up 22% from $86.4M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LFVN positions and 5 closed out — a net gain of 6 holders — while 35 added to existing stakes and 23 trimmed.

The largest buyer was Cadence Capital Management, opening a new position worth an estimated $1.97M. The largest seller was Oxford Asset Management, cutting an estimated $742K.

  • 86 institutional investors held LifeVantage (LFVN) as of Q4 2019, up from 80 in Q3 2019.
  • Funds reported $106M of LifeVantage stock for Q4 2019, up 22% quarter-over-quarter.
  • 11 funds opened new LifeVantage positions in Q4 2019 and 5 closed out, a net change of +6 holders.
  • The largest LifeVantage buyer in Q4 2019 was Cadence Capital Management, an estimated $1.97M added.
  • The largest LifeVantage seller in Q4 2019 was Oxford Asset Management, an estimated $742K sold.

Based on aggregated 13F filings for Q4 2019.